Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer
- PMID: 40057206
- DOI: 10.1016/j.bbadis.2025.167783
Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer
Abstract
Endocrine therapy resistance (ETR) in breast cancer (BC) is a multicausal phenomenon with diverse alterations in the tumor cell interactome. Within these alterations, non-coding RNAs (ncRNAs) such as micro-RNAs (miRNAs) modulate the expression of tumor suppressor genes and proto-oncogenes, such as the ESR1 gene encoding estrogen receptor alpha (ERα). This work aims to review the effects of miRNAs targeting ERα mRNA and their mechanisms related to ETR in BC. A thorough review of the literature and an in silico study were carried out to elucidate the involvement of each miRNA, thus contributing to the understanding of ETR in BC.
Keywords: Breast cancer; Endocrine therapy resistance; Estrogen receptor alpha; Noncoding RNAs; micro-RNAs.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The figures in this publication were created with BioRender.com.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
